FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308603083> ?p ?o ?g. }

• W4308603083 endingPage "2021" @default.
• W4308603083 startingPage "2010" @default.
• W4308603083 abstract "Background: Immune checkpoint inhibitors (ICIs) with or without chemotherapy represent first-line standard of care for patients with advanced non-small cell lung cancer (NSCLC) without targetable driver mutations. The most appropriate second-line therapy after failing immunochemotherapy remains an open question. Nintedanib, an oral triple angiokinase inhibitor that targets the vascular endothelial growth factor receptor, fibroblast growth factor receptor, and, platelet-derived growth factor receptor, in combination with docetaxel, is approved for treatment of advanced NSCLC (adenocarcinoma histology) following progression on first-line chemotherapy." @default.
• W4308603083 created "2022-11-13" @default.
• W4308603083 creator A5015898233 @default.
• W4308603083 creator A5024282182 @default.
• W4308603083 creator A5032314001 @default.
• W4308603083 creator A5036078463 @default.
• W4308603083 creator A5040589443 @default.
• W4308603083 creator A5041857102 @default.
• W4308603083 creator A5062659492 @default.
• W4308603083 creator A5067921018 @default.
• W4308603083 creator A5074420045 @default.
• W4308603083 creator A5075710937 @default.
• W4308603083 creator A5082092472 @default.
• W4308603083 creator A5087787245 @default.
• W4308603083 date "2022-10-01" @default.
• W4308603083 modified "2023-10-18" @default.
• W4308603083 title "Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO" @default.
• W4308603083 cites W2089756110 @default.
• W4308603083 cites W2104347254 @default.
• W4308603083 cites W2170030318 @default.
• W4308603083 cites W2198093519 @default.
• W4308603083 cites W2560367415 @default.
• W4308603083 cites W2567564314 @default.
• W4308603083 cites W2572174216 @default.
• W4308603083 cites W2734335426 @default.
• W4308603083 cites W2777674964 @default.
• W4308603083 cites W2782007611 @default.
• W4308603083 cites W2791328450 @default.
• W4308603083 cites W2796582438 @default.
• W4308603083 cites W2805354595 @default.
• W4308603083 cites W2898288153 @default.
• W4308603083 cites W2913247915 @default.
• W4308603083 cites W2961095395 @default.
• W4308603083 cites W3017713657 @default.
• W4308603083 cites W3048069045 @default.
• W4308603083 cites W3084622183 @default.
• W4308603083 cites W3110814768 @default.
• W4308603083 cites W3112930560 @default.
• W4308603083 cites W3121907365 @default.
• W4308603083 cites W3134778331 @default.
• W4308603083 cites W3138626659 @default.
• W4308603083 cites W3180979108 @default.
• W4308603083 cites W3186449511 @default.
• W4308603083 cites W4200468123 @default.
• W4308603083 cites W4205320263 @default.
• W4308603083 cites W4281721227 @default.
• W4308603083 doi "https://doi.org/10.21037/tlcr-21-1018" @default.
• W4308603083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36386456" @default.
• W4308603083 hasPublicationYear "2022" @default.
• W4308603083 type Work @default.
• W4308603083 citedByCount "4" @default.
• W4308603083 countsByYear W43086030832023 @default.
• W4308603083 crossrefType "journal-article" @default.
• W4308603083 hasAuthorship W4308603083A5015898233 @default.
• W4308603083 hasAuthorship W4308603083A5024282182 @default.
• W4308603083 hasAuthorship W4308603083A5032314001 @default.
• W4308603083 hasAuthorship W4308603083A5036078463 @default.
• W4308603083 hasAuthorship W4308603083A5040589443 @default.
• W4308603083 hasAuthorship W4308603083A5041857102 @default.
• W4308603083 hasAuthorship W4308603083A5062659492 @default.
• W4308603083 hasAuthorship W4308603083A5067921018 @default.
• W4308603083 hasAuthorship W4308603083A5074420045 @default.
• W4308603083 hasAuthorship W4308603083A5075710937 @default.
• W4308603083 hasAuthorship W4308603083A5082092472 @default.
• W4308603083 hasAuthorship W4308603083A5087787245 @default.
• W4308603083 hasBestOaLocation W43086030831 @default.
• W4308603083 hasConcept C121608353 @default.
• W4308603083 hasConcept C126322002 @default.
• W4308603083 hasConcept C143998085 @default.
• W4308603083 hasConcept C2776256026 @default.
• W4308603083 hasConcept C2776694085 @default.
• W4308603083 hasConcept C2777714996 @default.
• W4308603083 hasConcept C2778341716 @default.
• W4308603083 hasConcept C2779551604 @default.
• W4308603083 hasConcept C2780171596 @default.
• W4308603083 hasConcept C2780258809 @default.
• W4308603083 hasConcept C2781182431 @default.
• W4308603083 hasConcept C2781190966 @default.
• W4308603083 hasConcept C71924100 @default.
• W4308603083 hasConceptScore W4308603083C121608353 @default.
• W4308603083 hasConceptScore W4308603083C126322002 @default.
• W4308603083 hasConceptScore W4308603083C143998085 @default.
• W4308603083 hasConceptScore W4308603083C2776256026 @default.
• W4308603083 hasConceptScore W4308603083C2776694085 @default.
• W4308603083 hasConceptScore W4308603083C2777714996 @default.
• W4308603083 hasConceptScore W4308603083C2778341716 @default.
• W4308603083 hasConceptScore W4308603083C2779551604 @default.
• W4308603083 hasConceptScore W4308603083C2780171596 @default.
• W4308603083 hasConceptScore W4308603083C2780258809 @default.
• W4308603083 hasConceptScore W4308603083C2781182431 @default.
• W4308603083 hasConceptScore W4308603083C2781190966 @default.
• W4308603083 hasConceptScore W4308603083C71924100 @default.
• W4308603083 hasIssue "10" @default.
• W4308603083 hasLocation W43086030831 @default.
• W4308603083 hasLocation W43086030832 @default.
• W4308603083 hasLocation W43086030833 @default.
• W4308603083 hasOpenAccess W4308603083 @default.
• W4308603083 hasPrimaryLocation W43086030831 @default.

• next